ChinaBio(R) LLC Release: China Implements 30-Day Review For “Simple” M&A Transactions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

February 26, 2014 -- China has introduced new M&A review procedures that will shorten approval times for most transactions to 30 days. The Ministry of Commerce estimates that up to 60% of all M&A events will qualify for this new fast-track decision. The major determinant for fast-track approval is market share: the proposed tie-up cannot creat a company with a commanding position in its market. If the resulting market share is large, MOFCOM will require as long as 180 days to render an opinion. More details....

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC